HEALTH OFFICIALS. DOH Undersecretary Enrique Domingo, Secretary Francisco Duque III, and Undersecretary Mario Villaverde answer questions during a media forum on January 5, 2018. Photo by Mara Cepeda/Rappler If deaths or disease come to children who have gotten the dengue vaccine since March 2016, the health department asks parents to report the cases to UP-PGH
MANILA, Philippines (Jan. 6, 2018) — A panel of top doctors from the University of the Philippines-Philippine General Hospital (UP-PGH) is set to review the deaths of 14 children who had received the Dengvaxia dengue vaccine.
Continue reading UP-PGH to review deaths of 14 kids vaccinated with Dengvaxia INFO CAMPAIGN. DOH Secretary Francisco Duque III holds up a sample poster on Dengvaxia FAQs that will be put up in schools. Photo by Mara Cepeda/Rappler Health Secretary Francisco Duque III leaves it up the DOJ, the NBI, and non-governmental groups to go after Aquino administration officials and Sanofi Pasteur
MANILA, Philippines (Jan. 5, 2018) — Don’t expect the Department of Health (DOH) to file any cases against officials who should be held accountable for the now-suspended dengue vaccination program.
Continue reading DOH won’t file cases over Dengvaxia issue, will focus on kids’ safety RISKY VACCINE. A health worker shows off used vials of Dengvaxia vaccine inside the storage facility of the Department of Health on December 4, 2017. Photo by Ben Nabong/Rappler Sanofi is punished for failing to comply with post-marketing authorization requirements for its controversial dengue vaccine
MANILA, Philippines (Jan. 5, 2018) — Troubles continue for French pharmaceutical giant Sanofi Pasteur as the Philippines’ Food and Drug Administration (FDA) suspended its sale of the controversial Dengvaxia dengue vaccine for a year.
Continue reading FDA suspends Dengvaxia sale for a year, fines Sanofi P100,000 STOP THE SALE. A health worker shows used vials of Dengvaxia administered to students in Manila before Sanofi gave an update that the vaccine is risky for those who had no prior infection. Photo by Ben Nabong/Rappler The drug regulatory agency also directs pharma giant Sanofi to ‘conduct an information dissemination campaign through advisories, Dear Doctor letters, and patient fora’
MANILA, Philippines (Dec. 5, 2017) — The Food and Drug Administration on Monday night, December 4, ordered the French pharmaceutical company Sanofi Pasteur to pull out its Dengvaxia vaccine from the market, “pending compliance with the directives of the FDA.”
Continue reading FDA orders market pullout of Dengvaxia vaccine RISK. A health worker shows off used vials of Dengvaxia vaccine inside the storage facility of the local government health sector that was given to students during the school-based immunisation in Manila on December 4, 2017. Photo by Ben Nabong/Rappler Will Sanofi shoulder the costs of individuals who might contract severe dengue after receiving the vaccine? The company only says it is collaborating with the Department of Health
MANILA, Philippines (Dec. 4, 2017) — French pharmaceutical company Sanofi Pasteur said on Monday, December 4, there is no way of tracing who among the over 700,000 Filipino youth given the Dengvaxia vaccine are at risk from contracting severe dengue.
Continue reading Sanofi can’t trace individuals at risk, but continues to monitor Dengvaxia recipients